首页> 外文期刊>International Journal of Cancer =: Journal International du Cancer >Subclonal evolution of a classical Hodgkin lymphoma from a germinal center B-cell-derived mantle cell lymphoma
【24h】

Subclonal evolution of a classical Hodgkin lymphoma from a germinal center B-cell-derived mantle cell lymphoma

机译:来自生发中心B细胞的套细胞淋巴瘤的经典霍奇金淋巴瘤的亚克隆进化

获取原文
获取原文并翻译 | 示例
           

摘要

Composite lymphomas (CL) represent the occurrence of two distinct lymphomas in the same patient. Often, CL share a common cellular origin, thus representing a unique model to investigate the multistep genetic path leading to lymphomagenesis in general and to the specific development of each distinct lymphoma component in particular. Here, we present the molecular analysis of a case consisting of an unusual Hodgkin lymphoma (HL) and a mantle cell lymphoma (MCL), intimately admixed within one another in lymph nodes and bone marrow yet phenotypically distinct, in a patient who first presented with splenic/leukemic MCL two years earlier. MCL and Hodgkin and Reed/Sternberg (HRS) cells harbored identical immunoglobulin (Ig) VH gene rearrangements with shared somatic mutations, proving their common clonal origin from a (post-)germinal center (GC) B cell. This also demonstrates the (post-)GC origin of MCL with mutated IgV genes. Both lymphomas carried the same CCND1/IGH translocation and, unexpectedly for HL, expressed cyclin D1 and OCT2. Thus, HRS cells are able to preserve IGH locus activity (otherwise usually silenced in HL) to promote expression of an oncogene translocated into this locus. Both lymphoma populations further showed an identical TP53 function-impairing mutation, and later acquired a TP53 heterozygous deletion independently from one another (convergent evolution). The surprisingly close genetic relationship of the lymphomas, together with their histological intermingling and the clinical history of the patient, suggests subclonal evolution of HL from MCL as a plausible pathway in alternative to that so far described in CL, i.e. separate development from a common precursor. What's new? When two phenotypically distinct, yet genetically related lymphomas occur in one patient (composite lymphomas), this represents a unique opportunity to study the multistep transformation process in the pathogenesis of B cell lymphomas. Here, the authors present a case consisting of a Hodgkin and a mantle cell lymphoma. The two lymphomas were clonally related and carried the genetic translocation with the cyclin D1 gene translocated into the IGH locus, a characteristic for a mantle cell lymphoma. They further showed an identical TP53 function-impairing mutation, and later independently acquired a TP53 heterozygous deletion (convergent evolution). The authors see this close genetic relationship as evidence for subclonal evolution of a Hodgkin lymphoma from a mantle cell lymphoma.
机译:复合淋巴瘤(CL)代表同一患者中发生两种不同的淋巴瘤。通常,CL共有一个共同的细胞起源,因此代表了一个独特的模型,可以研究导致淋巴瘤发生的多步遗传途径,特别是每个独特的淋巴瘤成分的特异性发育。在这里,我们介绍了一个病例的分子分析,该病例由不寻常的霍奇金淋巴瘤(HL)和套细胞淋巴瘤(MCL)组成,在淋巴结和骨髓中彼此紧密混合,但在表型上不同,该患者首先出现脾/白血病MCL两年前。 MCL和Hodgkin和Reed / Sternberg(HRS)细胞具有相同的免疫球蛋白(Ig)VH基因重排,具有共同的体细胞突变,证明了它们的共同克隆起源于(后)发芽中心(GC)B细胞。这也证明了具有突变的IgV基因的MCL的(后)GC起源。两种淋巴瘤均具有相同的CCND1 / IGH易位,并且出乎意料的是,HL表达了细胞周期蛋白D1和OCT2。因此,HRS细胞能够保留IGH基因座活性(否则通常在HL中沉默),以促进转移到该基因座中的癌基因的表达。两种淋巴瘤种群进一步显示出相同的TP53功能受损突变,后来彼此独立获得了TP53杂合缺失(趋同进化)。淋巴瘤令人惊讶的密切遗传关系,以及它们的组织学混合和患者的临床病史,提示从MCL到HL的亚克隆进化是可行的途径,是迄今为止CL中所描述的替代途径,即与普通前体分开发展。什么是新的?当一名患者(复合淋巴瘤)中发生两种在表型上不同但遗传相关的淋巴瘤时,这代表了一个独特的机会来研究B细胞淋巴瘤发病机理中的多步转化过程。在这里,作者提出了一个由霍奇金和套细胞淋巴瘤组成的病例。这两个淋巴瘤具有克隆相关性,并通过细胞周期蛋白D1基因易位到IGH位点进行遗传易位,这是套细胞淋巴瘤的特征。他们进一步显示出相同的TP53功能受损突变,后来独立获得了TP53杂合缺失(趋同进化)。作者认为这种紧密的遗传关系是霍奇金淋巴瘤从套细胞淋巴瘤向亚克隆进化的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号